Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging and SSRI Efficacy in Bulimia Nervosa
NCT02359513Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Nov 2015
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine in bulimia nervosa (BN), sponsored by CHU Saint-Etienne. Started Nov 2015; status: completed.
02
Drugs
fluoxetine
03
Conditions
bulimia nervosa (BN)
Beyond the preview
Go deeper on NCT02359513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359513.